VKH
LABU icon

Virtu KCG Holdings’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Virtu KCG Holdings’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-935
Closed -$585K – 3474
2016
Q4 		$585K Buy
935
+365
+64% +$274K 0.01% 1341
2016
Q3 		$556K Sell
570
-1,199
-68% -$989K 0.01% 1265
2016
Q2 		$998K Buy
1,769
+1,164
+192% +$729K 0.02% 757
2016
Q1 		$332K Buy
605
+482
+392% +$305K 0.01% 1599
2015
Q4 		$207K Buy
+123
New +$199K ﹤0.01% 2668

Other funds holding LABU

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Virtu KCG Holdings's LABU Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2017, closing a stake of 935 shares — an estimated $585K sold.

Virtu KCG Holdings first reported a position in LABU in Q4 2015 and held it in 5 quarters. The position peaked at $998K in Q2 2016. 16 funds tracked by Wall St. Rank hold LABU as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 935 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2017, an estimated $585K.
  • Virtu KCG Holdings first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and held it in 5 quarters.
  • Virtu KCG Holdings's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $998K in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.